Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 06:06 am Purchase | 2024-12-10 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 268,758 10.700% | 5,167 (+1.96%) | Filing History |
| 2024-12-10 06:06 am Purchase | 2024-12-06 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 263,591 10.500% | 7,667 (+3.00%) | Filing History |
| 2024-12-05 07:45 am Purchase | 2024-12-03 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 255,925 10.000% | 75,729 (+42.03%) | Filing History |
| 2024-11-14 12:17 pm Sale | 2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 40,000 1.900% | -133,913 (-77.00%) | Filing History |
| 2024-09-16 10:22 am Purchase | 2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 173,913 8.500% | 173,913 (New Position) | Filing History |
| 2024-05-24 08:58 am Purchase | 2024-05-14 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 180,196 14.700% | 78,196 (+76.66%) | Filing History |
| 2024-01-08 11:01 am Purchase | 2023-12-29 | 13G | BriaCell Therapeutics Corp. BCTX | Copia Fund (Cayman) LP | 54,558 5.100% | 54,558 (New Position) | Filing History |
| 2023-02-14 4:35 pm Purchase | 2022-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 97,333 9.300% | 39,333 (+67.82%) | Filing History |
| 2022-08-01 07:00 am Purchase | 2022-07-20 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 58,000 5.600% | 5,667 (+10.83%) | Filing History |
| 2022-04-25 4:05 pm Purchase | 2022-04-14 | 13G | BriaCell Therapeutics Corp. BCTX | Southwest Private Capital Inc. | 52,134 5.100% | 52,134 (New Position) | Filing History |
| 2022-02-14 3:21 pm Unchanged | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 40,000 3.600% | 0 (Unchanged) | Filing History |
| 2022-02-11 8:39 pm Purchase | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Altium Capital Management LLC | 60,000 4.700% | 26,667 (+80.00%) | Filing History |
| 2022-02-11 5:47 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 7,000 11.000% | -59,667 (-89.50%) | Filing History |
| 2022-02-11 5:01 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 2,443 0.200% | -35,063 (-93.49%) | Filing History |
| 2022-02-11 08:00 am Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 52,333 4.920% | -6,333 (-10.80%) | Filing History |
| 2022-02-04 4:35 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | BIGGER CAPITAL FUND L P | 10,000 11.000% | -139,000 (-93.29%) | Filing History |
| 2022-01-20 09:47 am Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Empery Asset Management LP | 33,333 2.520% | -760 (-2.23%) | Filing History |
| 2022-01-03 7:24 pm Purchase | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | SABBY MANAGEMENT LLC | 50,459 11.000% | 13,459 (+36.38%) | Filing History |
| 2021-09-20 5:25 pm Sale | 2021-09-16 | 13D | BriaCell Therapeutics Corp. BCTX | Hyperscale Data Inc. GPUS | 47,667 4.670% | -11,333 (-19.21%) | Filing History |
| 2021-09-13 08:30 am Purchase | 2021-09-02 | 13G | BriaCell Therapeutics Corp. BCTX | K.J. Harrison & Partners Inc | 63,991 6.230% | 63,991 (New Position) | Filing History |